Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Cerebrolysin on Neurodevelopmental Outcome of Preterm Infants

NCT03506841 is registered in ClinicalTrials.gov with Mansoura University Children Hospital as lead sponsor.

NCT NCT03506841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03506841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Cerebrolysin on Neurodevelopmental Outcome of Preterm Infants
Lead sponsor
Mansoura University Children Hospital
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2016
Completion date
June 30, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, infant development, preterm infant